Literature DB >> 17540857

Angiogenic effects of human multipotent stromal cell conditioned medium activate the PI3K-Akt pathway in hypoxic endothelial cells to inhibit apoptosis, increase survival, and stimulate angiogenesis.

Shih-Chieh Hung1, Radhika R Pochampally, Sy-Chi Chen, Shu-Ching Hsu, Darwin J Prockop.   

Abstract

Recent reports indicated that vascular remodeling and angiogenesis are promoted by conditioned medium from the cells referred to as multipotent stromal cells (MSCs). However, the molecular events triggered by MSC-conditioned medium (CdM) were not defined. We examined the effects of CdM from human MSCs on cultures of primary human aortic endothelial cells (HAECs). The CdM inhibited hypoxia-induced apoptosis and cell death of HAECs. It also promoted tube formation by HAECs in an assay in vitro. Conditioned medium from multipotent stromal cells incubated under hypoxic conditions in serum-free endothelial basal medium for 2 days (CdM(Hyp)) from hypoxic culture of MSCs was more effective than conditioned medium from MSCs incubated under normoxic conditions in serum-free endothelial basal medium for 2 days from normoxic cultures of MSCs, an observation in part explained by its higher content of antiapoptotic and angiogenic factors, such as interleukin (IL)-6, vascular endothelial growth factor (VEGF), and monocyte chemoattractant protein (MCP)-1. The effects of CdM(Hyp) on hypoxic HAECs were partially duplicated by the addition of IL-6 in a dose-dependent manner; however, anti-IL-6, anti-MCP-1, and anti-VEGF blocking antibodies added independently did not attenuate the effects. Also, addition of CdM(Hyp) activated the PI3K-Akt pathway; the levels of p-Akt and several of its downstream targets were increased by CdM(Hyp), and both the increase in p-Akt and the increase in angiogenesis were blocked by an inhibitor of PI3K-Akt or by expression of a dominant negative gene for PI3K. CdM(Hyp) also increased the levels of p-extracellular signal-regulated kinase (ERK), but there was a minimal effect on p-signal transducer and activator of transcription-3, and an inhibitor of the ERK1/2 pathway had no effect on hypoxia-induced apoptosis of the HAECs. The results are consistent with suggestions that administration of MSCs or factors secreted by MSCs may provide a therapeutic method of decreasing apoptosis and enhancing angiogenesis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17540857     DOI: 10.1634/stemcells.2006-0686

Source DB:  PubMed          Journal:  Stem Cells        ISSN: 1066-5099            Impact factor:   6.277


  154 in total

1.  Use of human embryonic stem cell derived-mesenchymal cells for cardiac repair.

Authors:  David L Simpson; Nolan L Boyd; Sunjay Kaushal; Steve L Stice; Samuel C Dudley
Journal:  Biotechnol Bioeng       Date:  2011-09-02       Impact factor: 4.530

2.  Interleukin-25 enhances the capacity of mesenchymal stem cells to induce intestinal epithelial cell regeneration.

Authors:  Jingling Su; Chenxi Xie; Yanyun Fan; Weizi Cheng; Yiqun Hu; Qingwen Huang; Huaxiu Shi; Lin Wang; Jianlin Ren
Journal:  Am J Transl Res       Date:  2017-12-15       Impact factor: 4.060

3.  Influence of adult mesenchymal stem cells on in vitro vascular formation.

Authors:  J Michael Sorrell; Marilyn A Baber; Arnold I Caplan
Journal:  Tissue Eng Part A       Date:  2009-07       Impact factor: 3.845

Review 4.  Mechanisms of Cardiac Repair and Regeneration.

Authors:  Kathleen M Broughton; Bingyan J Wang; Fareheh Firouzi; Farid Khalafalla; Stefanie Dimmeler; Francisco Fernandez-Aviles; Mark A Sussman
Journal:  Circ Res       Date:  2018-04-13       Impact factor: 17.367

5.  Kidney-derived mesenchymal stem cells contribute to vasculogenesis, angiogenesis and endothelial repair.

Authors:  Jun Chen; Hyeong-Cheon Park; Francesco Addabbo; Jie Ni; Edward Pelger; Houwei Li; Matthew Plotkin; Michael S Goligorsky
Journal:  Kidney Int       Date:  2008-07-02       Impact factor: 10.612

6.  Human embryonic stem cell-derived mesenchymal stromal cell transplantation in a rat hind limb injury model.

Authors:  Juha P Laurila; Lilja Laatikainen; Maria D Castellone; Parul Trivedi; Jari Heikkila; Ari Hinkkanen; Peiman Hematti; Mikko O Laukkanen
Journal:  Cytotherapy       Date:  2009       Impact factor: 5.414

7.  Conditioned mesenchymal stem cells produce pleiotropic gut trophic factors.

Authors:  Shuhei Watanabe; Yoshiaki Arimura; Kanna Nagaishi; Hiroyuki Isshiki; Kei Onodera; Masanao Nasuno; Kentaro Yamashita; Masashi Idogawa; Yasuyoshi Naishiro; Masaki Murata; Yasushi Adachi; Mineko Fujimiya; Kohzoh Imai; Yasuhisa Shinomura
Journal:  J Gastroenterol       Date:  2013-11-12       Impact factor: 7.527

Review 8.  In Vitro Innovation of Tendon Tissue Engineering Strategies.

Authors:  Maria Rita Citeroni; Maria Camilla Ciardulli; Valentina Russo; Giovanna Della Porta; Annunziata Mauro; Mohammad El Khatib; Miriam Di Mattia; Devis Galesso; Carlo Barbera; Nicholas R Forsyth; Nicola Maffulli; Barbara Barboni
Journal:  Int J Mol Sci       Date:  2020-09-14       Impact factor: 5.923

Review 9.  The role of hypoxia in stem cell differentiation and therapeutics.

Authors:  Hamid Abdollahi; Lisa J Harris; Ping Zhang; Stephen McIlhenny; Vikram Srinivas; Thomas Tulenko; Paul J DiMuzio
Journal:  J Surg Res       Date:  2009-10-24       Impact factor: 2.192

10.  Biomaterials functionalized with MSC secreted extracellular vesicles and soluble factors for tissue regeneration.

Authors:  Meadhbh Á Brennan; Pierre Layrolle; David J Mooney
Journal:  Adv Funct Mater       Date:  2020-03-11       Impact factor: 18.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.